K Bilek

1.1k total citations
56 papers, 805 citations indexed

About

K Bilek is a scholar working on Obstetrics and Gynecology, Epidemiology and Reproductive Medicine. According to data from OpenAlex, K Bilek has authored 56 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Obstetrics and Gynecology, 22 papers in Epidemiology and 14 papers in Reproductive Medicine. Recurrent topics in K Bilek's work include Endometrial and Cervical Cancer Treatments (26 papers), Cervical Cancer and HPV Research (18 papers) and Ovarian cancer diagnosis and treatment (12 papers). K Bilek is often cited by papers focused on Endometrial and Cervical Cancer Treatments (26 papers), Cervical Cancer and HPV Research (18 papers) and Ovarian cancer diagnosis and treatment (12 papers). K Bilek collaborates with scholars based in Germany and Austria. K Bilek's co-authors include Bettina Hentschel, Lars‐Christian Horn, Uta Fischer, L.-C. Horn, J. Einenkel, U Schnurrbusch, Jens Einenkel, Cornelia Leo, K Rothe and Mattea Dallacker and has published in prestigious journals such as Gynecologic Oncology, European Journal of Obstetrics & Gynecology and Reproductive Biology and Journal of Cancer Research and Clinical Oncology.

In The Last Decade

K Bilek

54 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Bilek Germany 15 508 329 272 188 155 56 805
Charles Whitney United States 10 354 0.7× 227 0.7× 483 1.8× 199 1.1× 119 0.8× 12 743
Nadia Ismiil Canada 18 637 1.3× 247 0.8× 587 2.2× 134 0.7× 184 1.2× 40 1.0k
C. López‐Graniel Mexico 16 377 0.7× 222 0.7× 186 0.7× 331 1.8× 169 1.1× 31 667
Marit Ek United States 9 503 1.0× 114 0.3× 618 2.3× 96 0.5× 149 1.0× 11 893
Choutatsu Tsukayama Japan 15 194 0.4× 310 0.9× 139 0.5× 203 1.1× 319 2.1× 24 801
Tomoko Haba Japan 13 185 0.4× 166 0.5× 138 0.5× 253 1.3× 169 1.1× 30 928
Pascasio Aguirre United States 11 163 0.3× 243 0.7× 279 1.0× 225 1.2× 110 0.7× 12 668
Joshua Z. Press Canada 17 417 0.8× 162 0.5× 410 1.5× 183 1.0× 230 1.5× 27 985
Assumpció Pérez‐Benavente Spain 20 685 1.3× 252 0.8× 487 1.8× 379 2.0× 197 1.3× 73 1.1k
Kazuya Ariyoshi Japan 11 354 0.7× 103 0.3× 356 1.3× 91 0.5× 159 1.0× 34 629

Countries citing papers authored by K Bilek

Since Specialization
Citations

This map shows the geographic impact of K Bilek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Bilek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Bilek more than expected).

Fields of papers citing papers by K Bilek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Bilek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Bilek. The network helps show where K Bilek may publish in the future.

Co-authorship network of co-authors of K Bilek

This figure shows the co-authorship network connecting the top 25 collaborators of K Bilek. A scholar is included among the top collaborators of K Bilek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Bilek. K Bilek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horn, Lars‐Christian, K Bilek, Uta Fischer, Jens Einenkel, & Bettina Hentschel. (2014). A cut-off value of 2cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer. Gynecologic Oncology. 134(1). 42–46. 36 indexed citations
2.
Dallacker, Mattea, et al.. (2009). Karzinosarkome (maligne Müller-Mischtumoren) des Uterus: Morphologie, molekulare Pathogenese und morphologische Prognosefaktoren. Der Pathologe. 30(4). 292–301. 4 indexed citations
3.
Horn, L.-C., et al.. (2007). Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecologic Oncology. 107(2). 310–315. 92 indexed citations
4.
Horn, Lars‐Christian, Jeanett Edelmann, Bettina Hentschel, et al.. (2006). p16, p14, p53, and Cyclin D1 Expression and HPV Analysis in Small Cell Carcinomas of the Uterine Cervix. International Journal of Gynecological Pathology. 25(2). 182–186. 40 indexed citations
5.
Bilek, K, et al.. (2004). Expression of COX-2 and HER-2/neu and estrogen and progesterone receptor in primary squamous cell carcinomas of the endometrium. Journal of Cancer Research and Clinical Oncology. 131(4). 226–228. 3 indexed citations
6.
Horn, Lars‐Christian, U Schnurrbusch, K Bilek, Bettina Hentschel, & J. Einenkel. (2004). Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment. International Journal of Gynecological Cancer. 14(2). 348–353. 107 indexed citations
7.
Horn, L.-C., et al.. (2001). Pathologisch-anatomische Aufarbeitung und morphologische Basisinformationen für das Management von Dysplasien und Karzinomen der Cervix uteri. Zentralblatt für Gynäkologie. 123(5). 255–265. 8 indexed citations
8.
Horn, Lars‐Christian & K Bilek. (2001). Krebsregister beim Zervixkarzinom - sinnvoll und notwendig?. Zentralblatt für Gynäkologie. 123(5). 311–314. 7 indexed citations
9.
Fischer, Uta, et al.. (2001). Histopathologische Prognosefaktoren beim primär operativ therapierten Zervixkarzinom. Zentralblatt für Gynäkologie. 123(5). 266–274. 5 indexed citations
10.
Horn, Lars‐Christian, et al.. (2001). p53 in Surgically Treated and Pathologically Staged Cervical Cancer: Correlation with Local Tumor Progression, But Not with Lymphatic Spread. Pathology - Research and Practice. 197(9). 605–609. 14 indexed citations
11.
Horn, Lars‐Christian, et al.. (1997). Postpartal gestational choriocarcinoma fatally misdiagnosed as squamous cell cancer of the uterine cervix.. PubMed. 143(2-3). 191–6. 5 indexed citations
12.
Köhler, Uwe, et al.. (1997). Tumor-Associated Proteolytic Factors uPA and PAI-1 in Endometrial Carcinoma. Gynecologic Oncology. 66(2). 268–274. 21 indexed citations
13.
Bilek, K, et al.. (1996). Diagnosis and clinical management in malignant M�llerian tumors of the fallopian tube. Archives of Gynecology and Obstetrics. 258(1). 47–53. 12 indexed citations
14.
Bilek, K, et al.. (1995). CD 44 exon v6 as a predictor of lymphatic metastases in cervical carcinoma ? an immunocytochemical study of 94 cases. Archives of Gynecology and Obstetrics. 256(3). 147–153. 10 indexed citations
15.
Ebeling, K, K Bilek, E Rohde, et al.. (1989). Mikroinvasives Karzinom der Cervix uteri Stadium Ia-Ergebnisse einer multizentrischen klinikbezogenen Analyse. Geburtshilfe und Frauenheilkunde. 49(9). 776–781. 9 indexed citations
16.
Bilek, K, et al.. (1967). Das Verhalten des Erythrocytenzinks in der Schwangerschaft. Archives of Gynecology and Obstetrics. 204(4). 97–106. 1 indexed citations
17.
Bilek, K, et al.. (1962). Zum Verhalten des Serumkupfers bei weiblichen Genitalcarcinomen in Abh�ngigkeit von der Lokalisation und der Therapieform. Archives of Gynecology and Obstetrics. 196(5). 447–456. 3 indexed citations
18.
Bilek, K, et al.. (1960). Harnzinkausscheidung bei Schwangerschaftstoxikosen. Archives of Gynecology and Obstetrics. 192(6). 591–600. 1 indexed citations
19.
Rothe, K, et al.. (1960). Das Harneisen in der normalen Sp�tschwangerschaft und bei Sp�ttoxikosen. Archives of Gynecology and Obstetrics. 194(2). 113–125. 3 indexed citations
20.
Rothe, K, et al.. (1960). Das Serumzink in der normalen Schwangerschaft sowie bei Fr�h- und Sp�ttoxikosen. Archives of Gynecology and Obstetrics. 192(4). 349–364. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles Whitney Breakdown of academic impact, for papers by Nadia Ismiil Breakdown of academic impact, for papers by C. López‐Graniel Breakdown of academic impact, for papers by Marit Ek Breakdown of academic impact, for papers by Choutatsu Tsukayama Breakdown of academic impact, for papers by Tomoko Haba Breakdown of academic impact, for papers by Pascasio Aguirre Breakdown of academic impact, for papers by Joshua Z. Press Breakdown of academic impact, for papers by Assumpció Pérez‐Benavente Breakdown of academic impact, for papers by Kazuya Ariyoshi
Rankless by CCL
2026